KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Free Cash Flow: 2009-2024

Historic Free Cash Flow for Rigel Pharmaceuticals (RIGL) over the last 16 years, with Dec 2024 value amounting to $31.4 million.

  • Rigel Pharmaceuticals' Free Cash Flow rose 10.85% to $24.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $68.2 million, marking a year-over-year increase of 535.27%. This contributed to the annual value of $31.4 million for FY2024, which is 647.36% up from last year.
  • Rigel Pharmaceuticals' Free Cash Flow amounted to $31.4 million in FY2024, which was up 647.36% from -$5.7 million recorded in FY2023.
  • Over the past 5 years, Rigel Pharmaceuticals' Free Cash Flow peaked at $31.4 million during FY2024, and registered a low of -$74.2 million during FY2022.
  • Over the past 3 years, Rigel Pharmaceuticals' median Free Cash Flow value was -$5.7 million (recorded in 2023), while the average stood at -$16.2 million.
  • In the last 5 years, Rigel Pharmaceuticals' Free Cash Flow plummeted by 1,513.22% in 2022 and then soared by 647.36% in 2024.
  • Yearly analysis of 5 years shows Rigel Pharmaceuticals' Free Cash Flow stood at -$53.4 million in 2020, then surged by 109.82% to $5.3 million in 2021, then crashed by 1,513.22% to -$74.2 million in 2022, then surged by 92.26% to -$5.7 million in 2023, then spiked by 647.36% to $31.4 million in 2024.